Acen Corporation
Acen Corporation Fundamental Analysis
Acen Corporation (ACPIF) shows weak financial fundamentals with a PE ratio of 25.85, profit margin of 13.78%, and ROE of 3.13%. The company generates $34.2B in annual revenue with weak year-over-year growth of -15.86%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 12.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ACPIF's fundamental strength across five key dimensions:
Efficiency Score
WeakACPIF struggles to generate sufficient returns from assets.
Valuation Score
ModerateACPIF shows balanced valuation metrics.
Growth Score
WeakACPIF faces weak or negative growth trends.
Financial Health Score
ModerateACPIF shows balanced financial health with some risks.
Profitability Score
WeakACPIF struggles to sustain strong margins.
Key Financial Metrics
Is ACPIF Expensive or Cheap?
P/E Ratio
ACPIF trades at 25.85 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, ACPIF's PEG of -0.01 indicates potential undervaluation.
Price to Book
The market values Acen Corporation at 0.79 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -6.49 times EBITDA. This is generally considered low.
How Well Does ACPIF Make Money?
Net Profit Margin
For every $100 in sales, Acen Corporation keeps $13.78 as profit after all expenses.
Operating Margin
Core operations generate 6.73 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.13 in profit for every $100 of shareholder equity.
ROA
Acen Corporation generates $1.25 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Acen Corporation generates limited operating cash flow of $2.99B, signaling weaker underlying cash strength.
Free Cash Flow
Acen Corporation generates weak or negative free cash flow of $-13.47B, restricting financial flexibility.
FCF Per Share
Each share generates $-0.34 in free cash annually.
FCF Yield
ACPIF converts -11.06% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.85
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.01
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.79
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.21
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.54
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.03
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.007
vs 25 benchmark
How ACPIF Stacks Against Its Sector Peers
| Metric | ACPIF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.85 | 19.66 | Worse (Expensive) |
| ROE | 3.13% | 904.00% | Weak |
| Net Margin | 13.78% | 860.00% | Weak |
| Debt/Equity | 1.21 | 1.40 | Neutral |
| Current Ratio | 1.54 | 1.39 | Neutral |
| ROA | 1.25% | -4827.00% (disorted) | Weak |
ACPIF outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Acen Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-58.86%
Industry Style: Defensive, Dividend, Income
DecliningEPS CAGR
-76.21%
Industry Style: Defensive, Dividend, Income
DecliningFCF CAGR
-79.62%
Industry Style: Defensive, Dividend, Income
Declining